Article Versions Notes

Glavas Tahtler J, Djapic D, Neferanovic M, Miletic J, Milosevic M, Kralik K, Neskovic N, Tomas I, Mesaric D, Marjanovic K, et al. Long-Term Outcomes of Breast Cancer Patients Receiving Levobupivacaine Wound Infiltration or Diclofenac for Postoperative Pain Relief. Pharmaceutics. 2023; 15(9):2183. https://doi.org/10.3390/pharmaceutics15092183

Glavas Tahtler, Josipa, Dajana Djapic, Marina Neferanovic, Jelena Miletic, Marta Milosevic, Kristina Kralik, Nenad Neskovic, Ilijan Tomas, Dora Mesaric, Ksenija Marjanovic, and et al. 2023. "Long-Term Outcomes of Breast Cancer Patients Receiving Levobupivacaine Wound Infiltration or Diclofenac for Postoperative Pain Relief" Pharmaceutics 15, no. 9: 2183. https://doi.org/10.3390/pharmaceutics15092183

Glavas Tahtler, J., Djapic, D., Neferanovic, M., Miletic, J., Milosevic, M., Kralik, K., Neskovic, N., Tomas, I., Mesaric, D., Marjanovic, K., Rajc, J., Orkic, Z., Cicvaric, A., & Kvolik, S. (2023). Long-Term Outcomes of Breast Cancer Patients Receiving Levobupivacaine Wound Infiltration or Diclofenac for Postoperative Pain Relief. Pharmaceutics, 15(9), 2183. https://doi.org/10.3390/pharmaceutics15092183